Skip to main content

ATP Aptamer-Modified Quantum Dots with Reduced Glutathione/Adenosine Triphosphate Dual Response Features as a Potential Probe for Intracellular Drug Delivery Monitoring of Vesicular Nanocarriers

Buy Article:

$107.14 + tax (Refund Policy)

Nanoparticles have great promise in drug delivery, but their functional mechanisms are very complicated. Monitoring the payloads or carriers by conventional labeling strategies may result in an inaccurate perception of the effectiveness of nano drug delivery systems (NDDSs). A GSH/ATP dual-responsive fluorescence enhancement probe was developed by manipulating the electron transfer pathways of surface-modified quantum dots (QDs). Because the intracellular concentrations of GSH and ATP are one hundred times greater than those in the extracellular environment, the intracellular drug release process could be observed by the fluorescence signal of this probe after it is loaded into NDDSs as drug simulants. As a proof-of-concept investigation, the intracellular drug release behaviors of classical liposomes were studied by loading this probe, and the observed results strongly support the known drug delivery mechanism of these systems. Although more studies are needed to investigate the in vivo performance of the probe, this study may encourage further investigations of other intracellular environment-responsive smart probes for deciphering the in vivo fate of NDDSs.

Keywords: ATP APTAMER; FLUORESCENCE ENHANCING PROBE; GSH AND ATP DUAL RESPONSE; INTRACELLULAR DRUG DELIVERY MONITORING; QUANTUM DOTS

Document Type: Research Article

Publication date: 01 February 2019

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content